Jan 31, 2024 13:17
TLPH - Talphera, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.14 0.04 (3.51%) | --- | --- | 0.0 (0.0%) | 0.0 (0.0%) | -0.01 (-0.45%) | 0.09 (8.18%) | 0.09 (8.18%) |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.1
- Diluted EPS:
- Basic P/E:
- -11.8
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 1.18
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|